| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |